文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

高风险上消化道肿瘤切除术后癌症特异性手术风险分层预测模型

A Novel Predictive Model for Cancer-Specific Surgical Risk Stratification of Patients Undergoing High-Risk Upper Gastrointestinal Oncologic Resections.
PubMed 文献 · Ann Surg · 2025-09-12

研究基于2823例上消化道腺癌高风险切除患者,构建预测术后并发症和住院时间的列线图。并发症模型C-index为0.66,住院时间模型Kendall's Tau为0.39,内部验证显示模型可用于风险估计。

要点

  • 年龄、ASA>3、COPD、肾衰竭和手术时长是住院时间延长的独立危险因素。
  • 新辅助化疗和切皮前抗生素可缩短住院时间。
  • 并发症和住院时间列线图内部验证C-index为0.66,Kendall's Tau为0.39。

核心结论

  • 癌症特异性术前和术后列线图可用于估计高风险上消化道肿瘤切除术患者的住院时间和术后并发症风险。

研究设计与样本

  • 回顾性研究纳入2823例2015-2022年期间在Memorial Sloan Kettering Cancer Center接受上消化道腺癌高风险切除术的患者,包括胃切除术、食管切除术、远端胰腺切除术和胰十二指肠切除术。
  • 采用单变量和多变量分析筛选住院时间和并发症的危险因素,并构建列线图,通过1000次bootstrap重抽样进行内部验证。

主要发现

  • 中位住院时间为7.0天(IQR:6.0,10.0),总体30天术后并发症发生率为31%。
  • 多变量分析显示年龄、ASA>3、COPD、肾衰竭和手术时长是住院时间延长的独立危险因素(OR>1,P<0.05)。
  • 新辅助化疗和切皮前抗生素与住院时间缩短相关(OR<1,P<0.05)。
  • 并发症列线图的C-index为0.66,住院时间列线图的Kendall's Tau为0.39。
  • 手术类型、年龄、COPD病史和新辅助化疗对住院时间区分度最大;手术类型、种族和BMI对30天手术并发症影响最大。

临床怎么用

  • 该列线图可用于术前和术后评估高风险上消化道肿瘤切除术患者的住院时间和并发症风险,辅助临床决策和患者沟通。

局限性

  • 模型仅进行内部验证,未进行外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-risk oncologic resections are the primary curative interventions for solid upper gastrointestinal (GI) tumors; however, there are no cancer-specific risk-stratification models available for these operations. METHODS: We studied 2823 Memorial Sloan Kettering Cancer Center patients (2015-2022) undergoing upper GI oncologic resections including gastrectomy, esophagectomy, distal pancreatectomy, and pancreaticoduodenectomy for adenocarcinoma. Univariable analyses assessed risk factors for length of stay (LOS) and complications, with multivariable analyses incorporating covariates significant on univariable analysis and procedure type. Nomograms were built using multivariable models to predict surgical complications and LOS. Model performance was evaluated using discrimination (C-index for complications, Kendall's Tau for LOS) and calibration plots and was internally validated with 1000 bootstrap replicates to obtain average performance metrics and 95% confidence intervals. RESULTS: The median LOS was 7.0 (IQR:6.0,10.0), and the overall 30-day postoperative complication rates were 31%. Multivariable analysis identified age, ASA>3, COPD, renal failure, and operation length as independent risk factors for increased LOS (OR>1, P<0.05). Neoadjuvant chemotherapy (NAC) and pre-incision antibiotics reduced LOS (OR<1, P<0.05). The complication nomogram demonstrated a C-index of 0.66, while the LOS nomogram showed a Kendall's Tau of 0.39. Procedure type, age, and history of COPD and NAC had the greatest discriminatory values for LOS on the nomograms; procedure type, race, and BMI had the greatest impact on 30-day surgical complications. CONCLUSION: Our cancer-specific pre- and postoperative nomograms for LOS and postoperative complications provide an important tool to appropriately estimate risks and treatment outcomes for patients undergoing high-risk GI oncologic resections.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Abate M, Lin ST, Toumbacaris N, et al. A Novel Predictive Model for Cancer-Specific Surgical Risk Stratification of Patients Undergoing High-Risk Upper Gastrointestinal Oncologic Resections. Ann Surg. 2025. PMID: 40938700. doi:10.1097/SLA.0000000000006939

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。